Life Sciences

Japan has one of the world’s fastest growing elderly populations, driving growth in the huge Life Sciences market. In 2010, almost a quarter of Japan’s 127 million people were over 65. And this is predicted to increase to over 30% by 2025 and to 40% by 2055. Japanese society is therefore facing an increasing number of chronic and long-term diseases. After the US, Japan has the second largest healthcare, pharmaceutical and medical devices markets in the world. Total medical expenditure is over GBP 250 billion a year and the Japanese pharmaceutical market is bigger than both France and Germany's combined.

For the healthcare market, unique, sophisticated, and highly technical products are sought to assist elderly people, ranging from healthy elderly people to those with disabilities. For the medical devices market, opportunities exist with advanced and innovative products for exports of finished products, joint R&D and technology licensing-out. In pharmaceuticals, the demand for joint development, outsourcing of R&D, clinical trials and regulatory affairs to Europe continues to increase. 

Japan Time
18 Nov
2015
UK Time
18 Nov
2015

Japanese Legislation for Accelerating Drug Development

Japanese Legislation for Accelerating Drug Development: Webinar - Export to Japan
18 November 2015
18 November 2015
9:00am | UK Time
6pm | Japan Time
Online
Free

Join our free webinar to learn about the new legislations introduced by Japan's Health Ministry, which aim to support fast-track opportunities for orphan and innovative drugs for UK companies in Japan's pharmaceuticals market.

Japan Time
01 Oct 2015
~
30 Oct 2015
UK Time
01 Oct 2015
~
30 Oct 2015

Shionogi Seeks Research Partners

Shionogi Pharma Seeks Research Partners - Export to Japan
1 - 30 October 2015
1 - 30 October 2015
Month long event
Month long event
Online
Free

Apply for the SHIONOGI Science Program 2015 to receive funding and the opportunity for research collaboration with the Japanese research-based pharmaceutical company.

DefiniGEN: Leading the Way in Drug Discovery

: Leading the Way in Drug Discovery - Export to Japan

The use of DefiniGEN’s technologies in drug discovery provides pharmaceutical companies with more predictive in vitro cell products enabling the development of safer and more effective treatments. Read on to learn their tactic for entering the Japanese market. 

Themis Analytics Wins Business Development Trip

Themis Analytics wins business development trip

24 March 2015

Brian Hutchison of Themis Analytics was the lucky winner of return Business Class flights to Japan from our recent UKTI Japan customer survey competition. We caught up with him to find out a little more about the company's plans in the Japanese market and what in-roads they have made so far.

Japan Time
09 Mar
2015
UK Time
09 Mar
2015

Opportunities in Regenerative Medicine in Japan: Webinar

Opportunities in Regenerative Medicines in Japan - Export to Japan
9 March 2015
9 March 2015
9:30am | UK Time
9:30am | UK Time
Online
Free

Join our free webinar to learn about the regulatory frameworks for regenerative medicine in Japan, as well as opportunities for collaboration with the Forum for Innovative Regenerative Medicine (FIRM). 

Japan Time
27 Jan
2015
UK Time
27 Jan
2015

Regulatory Developments in Japan’s Medical Devices Market

Regulatory Developments in Japan’s Medical Devices Market: Webinar - Export to Japan
27 January 2015
27 January 2015
9:30am | UK Time
6:30pm | Japan Time
Online
Free

Join our free webinar to find out about the recent changes to Japan’s Pharmaceutical Affairs Law and how this will affect British medical devices and pharmaceutical companies wishing to do business in Japan. 

 

Five Trends In Japan That Matter To You

Five Trends In Japan That Matter To You - Export to Japan

The UK Trade & Investment team in Japan has pulled together the five trends that matter right now to businesses in Japan.  These include a shift towards low carbon, a globalising business environment, Japanese consumer appreciation of quality, authenticity & originality, an ageing society, and the removal of trade barriers.

Industry Insight: Chemicals Sector In Japan

Industry Insight: Chemicals Sector In Japan - Export to Japan

10 May 2014

Chemical companies here have been shifting from manufacturing commodity products to high value-added specialty chemicals, in particular for the booming pharmaceutical sector, which offers opportunities for British firms in the outsourced manufacturing of active ingredients and intermediaries, according to the London-based Chemical Industries Association. 

Doing Business with Daiichi Sankyo Report

Doing Business with Daiichi Sankyo Report - Export to Japan

An essential guide for companies in the Life Sciences sector seeking to expand into the Japanese market. This downloadable report will ensure you have the information you need to take advantage of future collaboration and research opportunities with Daiichi Sankyo.

Japan Time
04 Dec
2014
UK Time
04 Dec
2014

Innovation and Partnering with Eisai: Webinar

Innovation and Partnering with Eisai: Webinar - Export to Japan
4 December 2014
4 December 2014
9:30am | UK Time
6:30pm | Japan Time
Online
Free

Join this free webinar to learn from top performers in the Japanese pharmaceutical market, Eisai Co., Ltd., about open innovation and partnering strategies for future collaboration.

Doing Business with Shionogi Pharma Report

Doing Business with Shionogi Pharma Report

An essential guide for companies in the Life Sciences sector seeking to expand into the Japanese market. This downloadable report will ensure you are equipped with the information you need to establish the appropriate strategies to engage with Shionogi Pharma through their research interests. 

Japan Time
21 Oct
2014
UK Time
21 Oct
2014

Strategies for Collaboration and Partnering with Daiichi Sankyo

Strategies for Collaboration and Partnering with Daiichi Sankyo - Export t Japan
21 October 2014
21 October 2014
9:30am | UK Time
5:30pm | Japan Time
Online
Free

Join this free webinar to hear about strategies and opportunities to collaborate and partner with Daiichi Sankyo Co., Ltd, one of Japan’s leading research based pharmaceutical companies.

Japan Time
29 Sep
2014
UK Time
29 Sep
2014

Shionogi Pharma Talks R&D Collaboration: Webinar

Opportunities to Collaborate with Shionogi Pharma | Export to Japan
29 September 2014
29 September 2014
9:30am | UK Time
9:30am | UK Time
Online
Free

Join this free webinar to hear about opportunities to collaborate with Shionogi, one of Japan’s leading research based pharmaceutical companies.

Japan Time
30 Apr
2015
UK Time
30 Apr
2015

Cell Technology, Gene Therapy And Tissue Engineering In Japan

30 April 2015
30 April 2015
10:30am | Central European Time
10:30am | Central European Time
Online

Japan is a leading player in the field of biotechnology. EU-Japan Centre's webinar will allow you to understand the industry in Japan and make initial contact if your developments are right for the market. 

Webinar: Astellas Pharma Partnering Strategy

This webinar provides a detailed look at Japan's 2nd largest research based pharmaceutical company. Our guest speaker from Astellas explains their strategy for product development and examples of partnership opportunities your company could engage with.

This webinar provides a detailed look at Japan's 2nd largest research based pharmaceutical company. Our guest speaker from Astellas explains their strategy for product development and examples of partnership opportunities your company could engage with.

Japan Time
03 Apr
2014
UK Time
03 Apr
2014

Astellas Pharma: Business & Opportunity Webinar

UKTI Japan's Life Sciences team are delighted to announce the 2nd webinar of the series: “Learning from the Top Performers”, by inviting a senior speaker from Astellas Pharma Inc. Join this webinar to hear Mr Chihiro Yokota, Corporate Executive at Astellas Pharma, talk about thier business overview and what they are looking for in potential UK business partners.
3 April 2014
3 April 2014
9am | UK time
5pm | Japan time
Online
Free

UKTI Japan's Life Sciences team are delighted to announce the 2nd webinar of the series: “Learning from the Top Performers”, by inviting a senior speaker from Astellas Pharma Inc. Join this webinar to hear Mr Chihiro Yokota, Corporate Executive at Astellas Pharma, talk about their business overview and what they are looking for in potential UK business partners.

Pages